In conclusion, this study suggests that c-Myc can sustain mutp53 expression through the mevalonate pathway, and by doing so, maintains DDR and controls the oxidative stress, preventing pancreatic cancer cell death. This evidence concerns the gene MYC and pancreatic neoplasm.